Researchers at Washington University used new technology to unravel the entire genetic helix for a subset of breast cancer, called basal-like, and found that it is more like ovarian cancer than other types of breast cancer.
The study’s co-Leader, Mathew Ellis, said that means techniques used to tackle ovarian cancer could be more effective than traditional methods for basal-like breast cancer.
“The more we understand about an individual breast cancer the more we can actually treat the patient accurately,” Ellis said. “I like to call this genome forward medicine.”